PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1864-6433
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time ; day:6 ; month:10 ; year:2018 ; pages:1-9
Annals of nuclear medicine ; (6.10.2018), 1-9
- Urheber
-
Brumberg, Joachim
- Beteiligte Personen und Organisationen
-
Tran-Gia, Johannes
Lapa, Constantin Frederik Victor
Isaias, Ioannis U.
Samnick, Samuel
SpringerLink (Online service)
- DOI
-
10.1007/s12149-018-1305-5
- URN
-
urn:nbn:de:101:1-2018111508172387283390
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Brumberg, Joachim
- Tran-Gia, Johannes
- Lapa, Constantin Frederik Victor
- Isaias, Ioannis U.
- Samnick, Samuel
- SpringerLink (Online service)
Ähnliche Objekte (12)
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Parkinson’s disease gene, Synaptojanin1, dysregulates the surface maintenance of the dopamine transporter
11C-CFT PET brain imaging in Parkinson’s disease using a total-body PET/CT scanner
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
Parkinson
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Parkinson’s disease gene, Synaptojanin1, dysregulates the surface maintenance of the dopamine transporter
11C-CFT PET brain imaging in Parkinson’s disease using a total-body PET/CT scanner
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease
Parkinson
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson’s disease
Parkinson’s disease laterality: a 11C-PE2I PET imaging study
High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Parkinson’s disease gene, Synaptojanin1, dysregulates the surface maintenance of the dopamine transporter
11C-CFT PET brain imaging in Parkinson’s disease using a total-body PET/CT scanner
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease